NumFin

IQVIA Holdings Inc.

符号: IQV

NYSE

229.14

USD

今天的市场价格

  • 30.7152

    市盈率

  • -0.4065

    PEG比率

  • 41.75B

    MRK市值

  • 0.00%

    DIV收益率

IQVIA Holdings Inc. (IQV) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 IQVIA Holdings Inc. (IQV). 的默认数据。公司收入显示 8727.103 M 的平均值，即 0.105 % 增长率。整个期间的平均毛利润为 2756.896 M，即 0.110 %. 平均毛利率为 0.305 %. 公司去年的净收入增长率为 0.245 %，等于 0.935 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 IQVIA Holdings Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.053. 在流动资产领域，IQV 的报告货币为5596. 这些资产中的很大一部分，即 1496 是现金和短期投资。与去年的数据相比，该部分的变化率为0.143%. 公司的长期投资虽然不是其重点，但以报告货币计算的241（如果有的话）为241。这表明与上一报告期相比，48.765% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 12955. 这一数字表明，0.094% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 6112. 这方面的年同比变化率为 0.060%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为3413，存货估值为 0，商誉估值为 14567（如有. 无形资产总额（如果有）按 4839 估值. 应付账款和短期债务分别为 709 和 825. 债务总额为14231，债务净额为 12855. 其他流动负债为 3158，加上总负债 20569. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

balance-sheet.row.cash-and-short-term-investments

5895149613091477
1902
899
938
1005
1238
977.2
867.4
778.1
567.7
516.3

balance-sheet.row.short-term-investments

46912093111
88
62
47
46
40
-32.9
-34.5
-40.3
-36
-22.1

balance-sheet.row.net-receivables

13334341329602609
2466
2638
2463
2040
1741
1199.8
1020.6
940.4
763
716.5

balance-sheet.row.inventory

3560151156
159
138
151
146
123
154.1
166
137.6
105.2
81

balance-sheet.row.other-current-assets

2199687561521
563
451
322
259
235
80.9
92.1
89.5
74.1
51.7

balance-sheet.row.total-current-assets

21784559649814763
5090
4126
3874
3450
3337
2412
2146.1
1945.7
1510
1365.5

balance-sheet.row.property-plant-equipment-net

3229819863903
953
954
434
440
406
188.4
190.3
199.6
194
185.8

balance-sheet.row.goodwill

57549145671392113301
12654
12159
11800
11850
10727
719.7
464.4
409.6
302.4
278

balance-sheet.row.intangible-assets

19413483948204943
5205
5514
5951
6591
6390
368.1
280.2
298.1
272.8
269.4

balance-sheet.row.goodwill-and-intangible-assets

76962194061874118244
17859
17673
17751
18441
17117
1087.8
744.7
707.7
575.2
547.5

balance-sheet.row.long-term-investments

926241162164
162
152
142
78
82
85.3
66
63.3
55.1
33.9

balance-sheet.row.tax-assets

544166118124
114
119
109
98
89
42.7
36
32.9
37.3
78.2

balance-sheet.row.other-non-current-assets

1823453472491
386
227
239
235
177
110.1
122.8
117.7
127.5
112.1

balance-sheet.row.total-non-current-assets

83484210852035619926
19474
19125
18675
19292
17871
1514.3
1159.7
1121.1
989.2
957.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

105268266812533724689
24564
23251
22549
22742
21208
3926.3
3305.8
3066.8
2499.2
2322.9

balance-sheet.row.account-payables

1315970933162981
2813
2512
437
322
250
145.5
108.7
100.6
84.7
70

balance-sheet.row.short-term-debt

419582515291
149
100
100
103
92
48.5
0.8
10.4
55.7
20.1

balance-sheet.row.tax-payables

651116161137
102
108
100
72
76
35.2
55.7
35.8
9.6
47

balance-sheet.row.long-term-debt-total

50988129551285912347
12755
11941
10907
10122
7108
2419.3
2292.5
2035.6
2366.3
1951.7

Deferred Revenue Non Current

6554514640
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

1098---
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

13223158313344
344
319
1990
1746
1589
815.5
819
832.6
721
703.5

balance-sheet.row.total-non-current-liabilities

55188140781399413406
13726
13043
12061
11480
9643
2667.8
2537.9
2252
2540.2
2100.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

1114451264313
371
396
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

81259205691957218647
18284
16988
15595
14384
12348
4262
4009.8
3734.3
3858.2
3292.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2195231089810777
11095
11049
10901
10782
10602
8.8
143.8
478.1
4.6
1.2

balance-sheet.row.retained-earnings

17815469233342243
1277
998
807
655
-399
-461.6
-788.8
-1145.2
-1371.8
-994.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-3441-867-727-406
-205
-311
-224
46
-570
-111.4
-59.1
-0.4
7.7
22.9

balance-sheet.row.other-total-stockholders-equity

-123172284-7740-6572
-6166
-5733
-4770
-3374
-1000
228.5
0
0
0
0

balance-sheet.row.total-stockholders-equity

24009611257656042
6001
6003
6714
8109
8633
-335.7
-704
-667.4
-1359.5
-970.4

balance-sheet.row.total-liabilities-and-stockholders-equity

105268266812533724689
24564
23251
22549
22742
21208
3926.3
3305.8
3066.8
2499.2
2322.9

balance-sheet.row.minority-interest

0000
279
260
240
249
227
228.5
0
-0.1
0.5
0.8

balance-sheet.row.total-equity

24009611257656042
6280
6263
6954
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

105268---
-
-
-
-
-
-
-
-
-
-

Total Investments

955361161275
250
214
148
116
109
52.4
31.5
22.9
19.1
11.8

balance-sheet.row.total-debt

55838142311301112438
12904
12041
11007
10225
7200
2467.8
2293.3
2046
2422
1971.9

balance-sheet.row.net-debt

50412128551179511072
11090
11204
10116
9266
6002
1490.7
1426
1267.9
1854.3
1455.6

现金流量表

在 IQVIA Holdings Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.054 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了-99.972 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-1603000000.000. 与上一年相比， -0.201 发生了变化. 在同一时期，公司记录了 1125, 43 和 -752，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 1362，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010

cash-flows.row.net-income

135713581091971
308
227
284
1328
130
388.3
356.5
226
176.6
240.3
165.3

cash-flows.row.depreciation-and-amortization

1136112511301264
1287
1202
1141
1011
289
127.7
121
107.5
98.3
92
84.2

cash-flows.row.deferred-income-tax

-308-269-115-138
-176
-157
-177
-1216
135
18.4
-6.2
-24.2
16.6
-73.2
-9

cash-flows.row.stock-based-compensation

198217194170
95
146
113
106
80
37.8
30
22.8
25.9
14.1
17.3

cash-flows.row.change-in-working-capital

-121-280-84680
459
19
-106
-292
212
-69
-45.9
59.8
12.5
-82.5
103.3

cash-flows.row.account-receivables

-323-388-421-138
255
-124
-297
-142
-62
-246
-78.6
-151.7
-60.3
-115.7
2.8

cash-flows.row.inventory

12100-17
-229
-116
-184
-136
62
18.9
-33
32.6
-40.1
18.2
-20.7

cash-flows.row.account-payables

267267427244
253
240
368
90
160
104.3
45.8
107
58.3
67.4
38.9

cash-flows.row.other-working-capital

-121-159-90591
180
19
7
-104
52
53.8
19.9
71.9
54.5
-52.4
82.3

cash-flows.row.other-non-cash-items

576-244-5
-14
-20
-1
33
14
-27.5
-23.7
5.5
5.8
-29.7
17.1

cash-flows.row.net-cash-provided-by-operating-activities

2254000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-630-649-674-640
-616
-582
-459
-369
-164
-78.4
-82.7
-92.3
-71.3
-75.7
-80.2

cash-flows.row.acquisitions-net

-1009-876-1335-1463
-167
-588
-326
-827
1870
19.4
-96.7
-150
-47.4
-135.8
-101.9

cash-flows.row.purchases-of-investments

-63-83-5-10
-11
-25
-27
2
-40
-11
1.6
-0.3
-13.4
-32.7
-7.1

cash-flows.row.sales-maturities-of-investments

-29-3805
-2
-22
459
2
41
2.5
5.9
2.3
0.1
3
21.7

cash-flows.row.other-investing-activites

94385
0
27
-457
2
24
0.6
-1.3
0.1
-0.2
16.4
26

cash-flows.row.net-cash-used-for-investing-activites

-1695-1603-2006-2103
-796
-1190
-810
-1190
1731
-67
-173.1
-240.2
-132.2
-224.8
-141.4

cash-flows.row.debt-repayment

-2392-752-2659-2691
-2499
-3675
-3061
-4652
-1951
-2061.1
-182.8
-2448.4
-2000.9
-1719.9
-97.2

cash-flows.row.common-stock-issued

000-59
-44
11
15
91
97
64.3
35.2
525
3.5
1981.1
0.1

cash-flows.row.common-stock-repurchased

-805-992-1168-406
-447
-949
-1405
-2620
-1097
-515
-415.1
-6.4
-13.4
-14.3
-9.3

cash-flows.row.dividends-paid

000-59
-44
-11
-4076
-7163
-638
-2248.5
-425
-2073.3
-567.9
-288.3
-67.5

cash-flows.row.other-financing-activites

2622136234981980
2817
4348
8075
14272
1305
4511
857.3
4074.1
2431.8
-17.9
20.9

cash-flows.row.net-cash-used-provided-by-financing-activities

-575-382-329-1235
-217
-276
-452
-72
-2284
-249.2
-130.3
71
-146.9
-59.3
-153.1

cash-flows.row.effect-of-forex-changes-on-cash

-34-4-75-52
31
-5
-60
53
-86
-49.7
-39.1
-17.7
-5.2
-7.1
-2.8

cash-flows.row.net-change-in-cash

-50160-150-448
977
-54
-68
-239
221
109.8
89.2
210.4
51.4
-130.3
80.8

cash-flows.row.cash-at-end-of-period

5426137612161366
1814
837
891
959
1198
977.2
867.4
778.1
567.7
516.3
646.6

cash-flows.row.cash-at-beginning-of-period

5476121613661814
837
891
959
1198
977
867.4
778.1
567.7
516.3
646.6
565.8

cash-flows.row.operating-cash-flow

2254214922602942
1959
1417
1254
970
860
475.7
431.8
397.4
335.7
161
378.2

cash-flows.row.capital-expenditure

-630-649-674-640
-616
-582
-459
-369
-164
-78.4
-82.7
-92.3
-71.3
-75.7
-80.2

cash-flows.row.free-cash-flow

1624150015862302
1343
835
795
601
696
397.3
349.1
305
264.4
85.3
297.9

利润表行

IQVIA Holdings Inc. 的收入与上期相比变化了 0.041%。据报告, IQV 的毛利润为 4135。该公司的营业费用为 2053，与上年相比变化了 -35.864%. 折旧和摊销费用为 1125，与上一会计期间相比变化了 -0.011%. 营业费用报告为 2053，显示-35.864% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长0.157%. 营业收入为 2082，与上年相比变化了0.157%. 净利润的变化率为 0.245%。去年的净收入为1358.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010

income-statement-row.row.total-revenue

15113150051441013874
11359
11088
10412
9739
6878
5737.6
5460
5099.5
4865.5
4327.7
3924

income-statement-row.row.cost-of-revenue

103711087093829233
7500
7300
6746
6301
4750
4136.8
3978.3
3762.6
3632.6
3185.8
2804.8

income-statement-row.row.gross-profit

4742413550284641
3859
3788
3666
3438
2128
1600.8
1481.7
1336.9
1232.9
1142
1119.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

8712411301264
1287
1202
-5
-30
8
-2.4
9
0.2
3.6
-9.1
-15.6

income-statement-row.row.operating-expenses

2604205332013228
3076
2936
2857
2616
1300
921
882.3
860.5
817.8
762.3
698.4

income-statement-row.row.cost-and-expenses

12975129231258312461
10576
10236
9603
8917
6050
5057.8
4860.6
4623.1
4450.3
3948.1
3503.2

income-statement-row.row.interest-income

4136136
6
9
8
7
4
4.3
3.4
3.9
3.1
3.9
3.8

income-statement-row.row.interest-expense

709719416375
416
447
414
346
144
101.8
100.6
123.5
134.4
109.1
141.4

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-369-623-436-265
-358
-425
-75
-152
-209
-43.4
0
-33.7
-16.4
-89.9
-41.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

8712411301264
1287
1202
-5
-30
8
-2.4
9
0.2
3.6
-9.1
-15.6

income-statement-row.row.total-operating-expenses

-369-623-436-265
-358
-425
-75
-152
-209
-43.4
0
-33.7
-16.4
-89.9
-41.4

income-statement-row.row.interest-expense

709719416375
416
447
414
346
144
101.8
100.6
123.5
134.4
109.1
141.4

income-statement-row.row.depreciation-and-amortization

1136112511381420
1410
1323
1141
1011
289
127.7
121
107.5
98.3
92
84.2

income-statement-row.row.ebitda-caps

3343---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

2088208217991393
731
777
741
719
642
646.6
590.4
462.3
396.4
345.3
395

income-statement-row.row.income-before-tax

1437145913631128
373
352
328
331
479
539
502.2
323.1
267.4
184.7
241.7

income-statement-row.row.income-tax-expense

79101260163
72
116
59
-987
345
159
150.1
96
93.4
15.1
77.6

income-statement-row.row.net-income

135713581091966
279
191
259
1309
115
387.2
356.4
226.6
177.5
241.8
160.6
类似股票
您可能还对以下内容感兴趣：
RVTY
Revvity, Inc..
103.17 USD
NYSE
LAB
Standard BioTools Inc..
2.37 USD
NASDAQ
IDXX
IDEXX Laboratories, Inc..
483.68 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.295 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.71 AUD
ASX
DGX
Quest Diagnostics Incorporated.
136.94 USD
NYSE
QIA.DE
Qiagen N.V..
39.72 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
44.74 CNY
SHH
GTG.AX
Genetic Technologies Limited.
0.13 AUD
ASX
2395.T
Shin Nippon Biomedical Laboratories, Ltd..
1542 JPY
JPX

常见问题

什么是 IQVIA Holdings Inc. (IQV) 总资产是多少？

IQVIA Holdings Inc. (IQV) 总资产为 26681000000.000.

什么是企业年收入？

年收入为 7649000000.000.

企业利润率是多少？

公司利润率为 0.314.

什么是公司自由现金流？

自由现金流为 8.928.

什么是企业净利润率？

净利润率为 0.090.

企业总收入是多少？

总收入为 0.138.

什么是 IQVIA Holdings Inc. (IQV) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 1358000000.000.

公司总债务是多少？

债务总额为 14231000000.000.

营业费用是多少？

运营支出为 2053000000.000.

公司现金是多少？

企业现金为 1444000000.000.